NCT07349095

AI-Assisted Colorimetric Diagnosis of Peri-Implant Mucosal Erythema

Recruiting now NA Last updated 16 January 2026

What this trial tests

NA trial testing AIa assisted diagnosis in Peri-implant Mucositis in 200 participants. Currently enrolling.

Timeline

1 September 2025

Primary endpoint
30 January 2026

27 February 2026

Quick facts

Lead sponsor	Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	200
Start date	1 September 2025
Primary completion	30 January 2026
Estimated completion	27 February 2026
Sites	1 location across China

Drugs / interventions tested

• AIa assisted diagnosis

Conditions studied

• Peri-implant Mucositis — all drugs for Peri-implant Mucositis →

Sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Who can join

18 and older, any sex, with Peri-implant Mucositis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. Background and Rationale The visual diagnosis of peri-implant mucosal erythema (redness), a key sign of inflammation, is highly subjective and varies significantly among clinicians, leading to inconsistencies in early detection and monitoring of peri-implant diseases. There is a critical need for an objective, quantitative, and reliable tool to standardize this assessment. Recent advances in artificial intelligence (AI) and colorimetric analysis of digital intraoral scans offer a promising solution to this clinical challenge.
2. Primary Objectives

This diagnostic study aims to:

Develop and validate a core colorimetric index that objectively quantifies mucosal erythema from digital intraoral scan data.

Develop and validate an AI model that automatically calculates this index and provides a binary diagnosis (erythema present/absent) at the image level.

Develop and validate a second AI model for precise localization (object detection) of erythematous regions on standard clinical software screenshots.

Evaluate the clinical utility of the AI system by assessing its impact on the diagnostic accuracy, consistency, and confidence of clinicians with varying experience levels.
3. Study Design

This is a multiphase diagnostic accuracy study conducted at a single academic center. It comprises three sequential phases with independent validation:

Phase 1 (Development \& Internal Validation): Analysis of intraoral scans to derive the color index and train the AI models using an internal dataset.

Phase 2 (External Technical Validation): Prospective validation of the trained AI models on an independent cohort of patients from a separate branch of the hospital.

Phase 3 (Clinical Utility Assessment): A prospective, controlled, observer study where clinicians perform diagnoses with and without AI assistance.
4. Participants and Methods

Data Source: Adult patients with dental implants who received intraoral scans using a 3Shape TRIOS 3 scanner.

Image Data: Two formats are used: 1) Processed 3D surface files (PLY format) for colorimetric analysis, and 2) Standardized 2D screenshots from the 3Shape software for object detection.

Reference Standards: Expert consensus on erythema (primary) and Bleeding on Probing (BOP, clinical inflammatory standard).

AI Development: Deep learning models (e.g., convolutional neural networks) will be trained for index calculation, image-level diagnosis, and region localization.

Observer Study: Participating clinicians (experts, general dentists, and students) will diagnose a set of test images both unaided and with AI assistance (which displays the color index value and/or bounding boxes).
5. Key Outcome Measures

Diagnostic Accuracy: Area under the receiver operating characteristic curve (AUC), sensitivity, specificity (with 95% confidence intervals).

Technical Performance: Intraclass correlation coefficient (ICC) for automated measurement agreement; Mean Average Precision (mAP) and Dice Similarity Coefficient for object detection.

Clinical Impact: Change in diagnostic accuracy (AUC), inter-observer agreement (Kappa), and diagnostic confidence scores when using AI assistance.
6. Significance This study seeks to translate a subjective clinical sign into an objective, AI-powered diagnostic biomarker. If successful, the proposed system could become a valuable decision-support tool in daily practice and clinical research, promoting earlier, more consistent, and standardized monitoring of peri-implant tissue health, ultimately improving patient care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.